Switch theme
Sign up to access all valuation multiples
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.
1990
55
LTM Revenue $10.5M
LTM EBITDA $0.5M
$56.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
ArcticZymes has a last 12-month revenue (LTM) of $10.5M and a last 12-month EBITDA of $0.5M.
In the most recent fiscal year, ArcticZymes achieved revenue of $10.2M and an EBITDA of $1.7M.
ArcticZymes expects next 12-month revenue of XXX and NTM EBITDA of XXX
See ArcticZymes valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $10.5M | XXX | $10.2M | XXX | XXX | XXX |
| Gross Profit | $10.0M | XXX | $9.6M | XXX | XXX | XXX |
| Gross Margin | 95% | XXX | 94% | XXX | XXX | XXX |
| EBITDA | $0.5M | XXX | $1.7M | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 17% | XXX | XXX | XXX |
| EBIT | -$0.2M | XXX | -$0.1M | XXX | XXX | XXX |
| EBIT Margin | -2% | XXX | -1% | XXX | XXX | XXX |
| Net Profit | $0.6M | XXX | $0.8M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, ArcticZymes's stock price is NOK 16 (or $2).
ArcticZymes has current market cap of NOK 809M (or $79.1M), and EV of NOK 575M (or $56.2M).
See ArcticZymes trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $56.2M | $79.1M | XXX | XXX | XXX | XXX | $0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, ArcticZymes has market cap of $79.1M and EV of $56.2M.
ArcticZymes's trades at 5.5x EV/Revenue multiple, and 32.8x EV/EBITDA.
Equity research analysts estimate ArcticZymes's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ArcticZymes has a P/E ratio of 122.3x.
See valuation multiples for ArcticZymes and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $79.1M | XXX | $79.1M | XXX | XXX | XXX |
| EV (current) | $56.2M | XXX | $56.2M | XXX | XXX | XXX |
| EV/Revenue | 5.3x | XXX | 5.5x | XXX | XXX | XXX |
| EV/EBITDA | 118.2x | XXX | 32.8x | XXX | XXX | XXX |
| EV/EBIT | -304.3x | XXX | -399.4x | XXX | XXX | XXX |
| EV/Gross Profit | 5.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 122.3x | XXX | 95.6x | XXX | XXX | XXX |
| EV/FCF | -122.5x | XXX | -73.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialArcticZymes's last 12 month revenue growth is 10%
ArcticZymes's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
ArcticZymes's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
ArcticZymes's rule of X is 29% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for ArcticZymes and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 96% | XXX | -62% | XXX | XXX | XXX |
| Rule of 40 | 36% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 96% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Corbion | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| Industries Qatar | XXX | XXX | XXX | XXX | XXX | XXX |
| K+S | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ArcticZymes acquired XXX companies to date.
Last acquisition by ArcticZymes was XXXXXXXX, XXXXX XXXXX XXXXXX . ArcticZymes acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was ArcticZymes founded? | ArcticZymes was founded in 1990. |
| Where is ArcticZymes headquartered? | ArcticZymes is headquartered in Norway. |
| How many employees does ArcticZymes have? | As of today, ArcticZymes has 55 employees. |
| Who is the CEO of ArcticZymes? | ArcticZymes's CEO is Mr. Michael B. Akoh. |
| Is ArcticZymes publicy listed? | Yes, ArcticZymes is a public company listed on OSL. |
| What is the stock symbol of ArcticZymes? | ArcticZymes trades under AZT ticker. |
| When did ArcticZymes go public? | ArcticZymes went public in 2005. |
| Who are competitors of ArcticZymes? | Similar companies to ArcticZymes include e.g. Fertiglobe, Corbion, Gujarat State Fertilizers & Chemicals, Industries Qatar. |
| What is the current market cap of ArcticZymes? | ArcticZymes's current market cap is $79.1M |
| What is the current revenue of ArcticZymes? | ArcticZymes's last 12 months revenue is $10.5M. |
| What is the current revenue growth of ArcticZymes? | ArcticZymes revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of ArcticZymes? | Current revenue multiple of ArcticZymes is 5.3x. |
| Is ArcticZymes profitable? | Yes, ArcticZymes is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of ArcticZymes? | ArcticZymes's last 12 months EBITDA is $0.5M. |
| What is ArcticZymes's EBITDA margin? | ArcticZymes's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of ArcticZymes? | Current EBITDA multiple of ArcticZymes is 118.2x. |
| What is the current FCF of ArcticZymes? | ArcticZymes's last 12 months FCF is -$0.5M. |
| What is ArcticZymes's FCF margin? | ArcticZymes's last 12 months FCF margin is -4%. |
| What is the current EV/FCF multiple of ArcticZymes? | Current FCF multiple of ArcticZymes is -122.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
